Investor Presentation

Commercialisation Strategy Compelling Value Proposition For USA Healthcare System Improved Patient Experience • Non-invasive and fast imaging protocol - with simple to understand report outputs No patient compliance required - both lying and sitting options are possible Radiation dose is low allowing for more frequent lung assessments Earlier diagnosis provides improved patient outcomes at lower cost Improved Patient Outcomes • Technology has FDA Clearance for all lung conditions to maximize societal benefit • ICU bed & ventilator value multiplier in a pandemic or other emergency event • Novel end-point for clinical trials to support faster therapy development • Earlier diagnosis leads to earlier treatment and healthier population Superior patient monitoring capability Pg 25 Investor presentation Reduced Cost of Care Earlier diagnosis delivers earlier intervention and less cost for chronic disease management • Acute patient readmissions accounts for disproportionate costs (38% of COPD patients have 4-10 ER visits per year) • No additional hospital CapEx or OpEx required • • Fully automated production to deliver low cost/high value proposition vs other lung diagnostics Change in standard of care will reduce overall diagnostic costs H . Easy to Implement • • Seamless integration with standard radiology workstreams Rapid integration (possible 6 days, offsite) Leverages existing X-ray equipment/ infrastructure with no CapEx 4DMedical™ FORMERLY 4D

View entire presentation